Bank Of Montreal »

4d Molecular Therapeutics In shares owned by Bank Of Montreal

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Bank Of Montreal from 13F filings

Historical chart of Bank Of Montreal investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Bank Of Montreal consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Bank Of Montreal

Quarter filed Position value Share count Share price at filing
2023-12-31 $546k 26k 21.15
2021-03-31 $10k 244 40.98

More positions owned by Bank Of Montreal

Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Tesla Motors (TSLA)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Toronto Dominion Bk Ont Com New (TD)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bk Nova Cad (BNS)
Meta Platforms Cl A (META)
Cibc Cad (CM)
Bank Of Montreal Cadcom (BMO)
Walt Disney Company (DIS)

View all positions for Bank Of Montreal

Top funds holding 4d Molecular Therapeutics In

Viking Global Investors
RA Capital Management
BVF
VR Adviser
Henderson Group
Vanguard Group
Arrowpoint Asset Management
Casdin Capital
Goldman Sachs Group
Dimensional Fund Advisors
Deutsche Bank Aktiengesellschaft
Eagle Health Investments
Assenagon Asset Management
Jpmorgan Chase & Co
Point72 Asset Management

View all funds holding 4d Molecular Therapeutics In